← Back to Treatments
🏅 FDA Orphan Designation

Radicava

edaravone

Manufacturer: Tanabe Pharma America Inc.

Indicated for:
Amyotrophic Lateral Sclerosis (ALS)Orphan

FDA-Approved Indications (1)

Treatment of amyotrophic lateral sclerosis (ALS)

Indications & Usage

1 INDICATIONS AND USAGE RADICAVA and RADICAVA ORS are indicated for the treatment of amyotrophic lateral sclerosis (ALS). RADICAVA and RADICAVA ORS are indicated for the treatment of amyotrophic lateral sclerosis (ALS). ( 1 )

💙 Support Programs

View all →
Edaravone
Mitsubishi Tanabe
Copay card ↗Apply ↗
Radicava
Tanabe Pharma America Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.